Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $9.03 and traded as low as ...

Let’s look specifically at dexamethasone, a common corticosteroid in emergency medicine, and use current research to describe what the drug does and look at select situations in prehospital care ...

After hours: January 31 at 6:03:38 PM EST Loading Chart for HROW ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

Int Ophthalmol Clin. 2015;55(2):47-65.

After hours: January 28 at 4:58:03 p.m. EST ...

For example, two products were listed for oral dexamethasone solution, including a 0.5-mg/5-mL solution used in neonates and a concentrated 0.5-mg/0.5-mL solution for adults. The concentrated ...